Skip to main content

Cephalon, Inc. Investor Investigation Monitors Potential Takeover by Valeant Pharmaceuticals Intl

  • If you purchased shares of Cephalon, Inc. (NASDAQ:CEPH) prior to the announcement and currently hold those NASDAQ:CEPH) shares, and/or if you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

After Valeant Pharmaceuticals Intl, Inc. announced it intended to take over Cephalon, Inc. at $73 per CEPH share an investigation on behalf of investors in Cephalon, Inc. (NASDAQ:CEPH) concerning possible breaches of fiduciary duty was announced. The investigation by a law firm concerns whether certain directors and officers at Cephalon, Inc. or others breached or will breach their fi...



You must register (for free) or login to view the entire investigation.